Skip to content
Fast, tracked shipping COA with every lotFor Research Use Only
AminoRepo
GLP-1
In stock
GLP-3R research peptide vial
GLP-3R
≥99.0% HPLC · Lyophilized powder
GLP-1In stockGIP/GLP-1/glucagon triple agonist

GLP-3R

A metabolic-research peptide studied alongside single- and dual-incretin receptor agonists.

For Research Use OnlyNot for human consumption
Vial size
1
Subtotal
$46

Certificate of analysis on this page

View the HPLC and mass-spec report for the current lot of each vial size — and prior lots — in the certificates of analysis section below.

Fast, tracked shipping

Orders ship within 1–2 business days with tracking.

Research overview

GLP-3R (development code LY3437943) is a 39-residue synthetic peptide engineered as a single-molecule agonist of three class B G-protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). The backbone incorporates non-coded residues, including alpha-aminoisobutyric acid (Aib) at positions 2 and 20 and an alpha-methyl-leucine, together with a C-terminal amide; these are structural features studied for conferring resistance to dipeptidyl peptidase-4 (DPP-4) and exopeptidase cleavage in vitro. A C20 fatty diacid is conjugated through a gamma-Glu/AEEA linker at a lysine side chain, a motif characterized in published pharmacokinetic models for promoting reversible albumin association and prolonged plasma exposure.

As a reference standard, GLP-3R is used to interrogate the combined pharmacology of incretin and glucagon receptor signaling. In reported in-vitro assays it engages the human receptors with nanomolar-to-subnanomolar potency (EC50 values near 5.8 nM at GCGR, 0.06 nM at GIPR, and 0.78 nM at GLP-1R), and it has served as a tool compound in cell-based and rodent models probing glucose homeostasis, energy expenditure, and body-composition endpoints. Supplied lyophilized as a research reference standard; store at -20C. For research use only and not for human or veterinary use.

Also known as: LY3437943, LY-3437943

Lot 0413187 (10 mg) · Lot 0101176 (20 mg) · CAS 2381089-83-2 · MW 4731.33 g/mol · ≥99.0% HPLC

Research areas

  • GIP/GLP-1/glucagon receptor triple-agonism pharmacology
  • Incretin and glucagon signaling in energy-balance models
  • Structure-activity studies of fatty-acid-acylated peptide agonists
  • Comparative class B GPCR potency and selectivity profiling
Supplied as a lyophilized powder. Store at -20°C, protected from light and moisture.

Documentation

Certificates of analysis

Every lot is third-party tested by HPLC and mass spectrometry. Each vial size is produced and tested as its own lot — find your size below to view the certificate for its current lot, or pull the COA for an earlier lot you may already have on the bench.

10 mg vials

0413187
Current lot
View

20 mg vials

0101176
Current lot
View

Each certificate reports HPLC purity, mass-spectrometry identity, appearance, and net peptide content for that specific lot.